Profound Medical Corp

NASDAQ:PROF 3:59:45 PM EDT

12.08

-0.67 (-5.26%)

7:59:52 PM EDT: $13.00 +0.92 (+7.62%)

Market Cap (Intraday)	252.17M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$2.66 Million
Adjusted EPS	-$0.37

See more estimates

10-Day MA	$12.29
50-Day MA	$8.81
200-Day MA	$7.11

See more pivots

Profound Medical Corp Stock, NASDAQ:PROF

2400 Skymark Avenue, Unit 6, Mississauga, Ontario L4W 5K5

Canada

Phone: +1.647.476.1350

Number of Employees:

http://www.profoundmedical.com

Description

Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. The firm's platforms offer clinicians and patients incision-free alternatives to current standards of care, which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, Canada.